The RPS6KA3 gene gives cells instructions for a protein that passes growth and communication signals, especially in the brain and bones. This gene plays an important role in how the body supports learning, development, and bone growth. If this gene does not work properly, it can lead to Coffin-Lowry syndrome, a condition that may cause intellectual disability, short stature, delayed development, and characteristic facial or hand features. Because it sits on the X chromosome, effects often differ between males and females.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes carry the instructions for producing proteins, the parts of cells that do much of the work. Others mostly help regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes affect how the body develops and operates, and they can also influence how you respond to food, stress, or medications. To go deeper into this subject, you can learn more in the LearnHub.
Overview
RPS6KA3Gene function
What if the gene works
The RPS6KA3 gene helps cells pass along growth signals and turn other proteins on when needed. This supports normal brain development, bone growth, and everyday cell activity.
Risk
What if the gene does not work
Variants in the RPS6KA3 gene can cause Coffin-Lowry syndrome, often with developmental delay or intellectual disability, distinctive facial and hand features, and short stature. Milder to more severe variants can change which features appear and how strongly.
Treatment
What does that mean for your treatment
No treatment specifically targeted to pathogenic variants in the RPS6KA3 gene is currently established. Care is based on symptoms rather than on a drug choice linked to the gene result itself.
Conditions associated with RPS6KA3
Gene function
What if the gene works
Cells use the RPS6KA3 gene to pass along everyday growth and communication signals. Its protein helps turn outside messages into controlled actions inside the cell, including changes in protein activity and gene activity. Understanding what the RPS6KA3 gene does in cells helps explain how cells grow, adapt, and carry out routine tasks.
The RPS6KA3 gene makes a protein that carries growth and communication signals from the cell surface inward. This helps cells respond in an organized way to everyday cues from growth factors and other messengers.
Its protein is a kinase, which means it adds small phosphate tags to other proteins. These tags act like control marks that help other proteins turn on, turn off, or change their activity.
The RPS6KA3 protein can help control which genes are active after a signal reaches the cell. That supports normal cell growth, cell maturation, and steady day to day function.
The RPS6KA3 protein also helps link cell signals to the machinery that builds proteins. This lets cells adjust protein making to match routine demands and growth needs.
What is a variant?
A genetic variant is a slight difference in a gene’s DNA sequence. These differences are common and are part of typical human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RPS6KA3 gene can make the protein unstable, shorten it, or alter the part needed for its chemical signaling activity, so cell signaling becomes weaker or stops. This is how variants in the RPS6KA3 gene affect protein function at the cellular level. Milder variants may leave some activity, while more severe variants, including truncating variants or gene deletions, often remove activity almost completely. That range can influence how early Coffin-Lowry syndrome appears and how marked its features are.
How variants are linked to conditions
Pathogenic variants in the RPS6KA3 gene cause Coffin-Lowry syndrome, an X-linked condition that can affect learning, growth, facial features, and bone development. In people with RPS6KA3 gene variants and Coffin-Lowry syndrome, common features include developmental delay, short stature, and changes in the hands or spine. Effects often differ between males and females, with many females having milder features.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal part of human biology. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RPS6KA3, risk is mainly shaped by whether a disease-causing change is present and by sex, because males often have more severe effects while females can be milder or more variable. There is not enough evidence to say that lifestyle or environmental changes lower the chance of developing this condition.
Inheritance of RPS6KA3 variants
Variants in the RPS6KA3 gene are inherited in an X-linked dominant pattern, which means one altered copy on the X chromosome can be enough to cause an RPS6KA3-related condition such as Coffin-Lowry syndrome. If a mother carries the variant, each child has a 50% chance of inheriting it, while a father with the variant can pass it to all daughters and no sons. New, de novo variants are also well recognized, so some people with an RPS6KA3 gene change are the first in their family to have it.
What does my RPS6KA3 result mean for my family?
RPS6KA3 changes linked to Coffin-Lowry syndrome usually follow an X-linked pattern, so close relatives on the mother’s side may also carry the same change and may want to discuss family testing. The effect can be more severe in males, while females may have milder features or sometimes few obvious signs. Some cases happen for the first time in one person, so a parent may not have the same gene change.
Genetic information
Genetic testing
How you find out about variants
RPS6KA3 genetic testing usually uses a blood or saliva sample to read the RPS6KA3 gene and look for variants, including small spelling changes and missing or extra pieces. Results may identify a variant linked to the condition, find no relevant change, or show a variant of uncertain significance, which means its health effect is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the RPS6KA3 gene may be worth considering if someone has unexplained developmental delay or intellectual disability, especially with delayed speech, short stature, or unusual facial or hand features. It can also help when Coffin-Lowry syndrome is suspected or when there is a family history of this condition.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Over time, many factors help shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. People can process the same drug at different speeds, which may change how well it works or how sensitive they are to side effects. These differences are common and are one reason the same treatment can help one person more than another.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medication. It focuses on the relationship between genes and drugs to better explain why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body processes it. This understanding can support treatment choices that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the RPS6KA3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so concerns about side effects, new symptoms after starting treatment, or medication safety are best discussed with your doctor.
History
Coffin-Lowry syndrome was first described in the 1960s and early 1970s through reports by Dr. Grange Coffin and Dr. Robert Lowry, who recognized a recurring inherited pattern of developmental and skeletal features in affected families. Initially understood only through visible traits, it was later recognized as tied to a specific gene. In the 1990s, researchers identified the RPS6KA3 gene on the X chromosome as the cause in many families with this condition. From these first observations, research expanded steadily. That discovery helped confirm the X linked inheritance pattern and improved genetic diagnosis for relatives. Over time, studies of different RPS6KA3 variants clarified why features can vary from one person or family to another.